Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.12
- 0.02 (-1.75%)
Day High: 1.17
Day Low:  1.09
Volume:    85,583
4:00 PM ET on Jan 20, 2017

Delayed at least 20 minutes.

Events & Presentations

Upcoming events are not available at this time. Sign up for email alerts.